Company news
PolyPid Ltd. news in 2021
PolyPid Ltd.'s news releases, calls and decks from 2021, newest first.
PolyPid Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdominal Surgery
November 17, 2021
PolyPid Appoints New Oncology Advisory Board Member
November 15, 2021
PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
September 12, 2021
PolyPid Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Director
July 11, 2021
PolyPid Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program
May 18, 2021
PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections
February 15, 2021
PolyPid Ltd. Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
February 9, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (July 2021)
Investor deck · 22 slides · Jul 2, 2021